A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1.

Heterologous expression of unmodified recombinant human cytochrome P450 enzymes (P450s) in Escherichia coli has proved to be extremely difficult. To date, high-level expression has only been achieved after altering the 5'-end of the native cDNA, resulting in amino acid changes within the P450 protein chain. We have devised a strategy whereby unmodified P450s can be expressed to high levels in E. coli, by making NH2-terminal translational fusions to bacterial leader sequences. Using this approach, we initially tested two leader sequences, pelB and ompA, fused to CYP3A4. These were compared with an expression construct producing a conventional NH2-terminally modified CYP3A4 (17alpha-3A4). Both leader constructs produced spectrally active, functional protein. Furthermore, the ompA-3A4 fusion gave higher levels of expression, and a marked improvement in the recovery of active P450 in bacterial membrane fractions, when compared with 17alpha-3A4. We then tested the ompA leader with CYP2A6 and CYP2E1, again comparing with the conventional (17alpha-) approach. As before, the leader construct produced active enzyme, and, for CYP2E1 at least, gave a higher level of expression than the 17alpha-construct. The ompA fusion strategy thus appears to represent a significant advance for the expression of P450s in E. coli, circumventing the previous need for individual optimization of P450 sequences for expression.

[1]  C. Wolf,et al.  Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli , 1996, FEBS letters.

[2]  C. Wolf,et al.  Recombinant DNA technology as an investigative tool in drug metabolism research , 1996 .

[3]  F. Gonzalez,et al.  Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants. , 1996, Molecular pharmacology.

[4]  F. Guengerich,et al.  Identification of retained N-formylmethionine in bacterial recombinant mammalian cytochrome P450 proteins with the N-terminal sequence MALLLAVFL...: roles of residues 3-5 in retention and membrane topology. , 1996, Biochemistry.

[5]  J. Dong,et al.  Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli. , 1996, Archives of biochemistry and biophysics.

[6]  D W Nebert,et al.  P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. , 1996, Pharmacogenetics.

[7]  T. Richardson,et al.  A universal approach to the expression of human and rabbit cytochrome P450s of the 2C subfamily in Escherichia coli. , 1995, Archives of biochemistry and biophysics.

[8]  T. Sueyoshi,et al.  Molecular engineering of microsomal P450 2a-4 to a stable, water-soluble enzyme. , 1995, Archives of biochemistry and biophysics.

[9]  H. Yamazaki,et al.  Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates. , 1995, Biochemistry.

[10]  G Wang,et al.  High-level expression of prochymosin in Escherichia coli: effect of the secondary structure of the ribosome binding site. , 1995, Protein expression and purification.

[11]  M. Inouye,et al.  Role of the AGA/AGG codons, the rarest codons in global gene expression in Escherichia coli. , 1994, Genes & development.

[12]  K. Korzekwa,et al.  cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. , 1994, Drug metabolism and disposition: the biological fate of chemicals.

[13]  F. Guengerich,et al.  Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. , 1994, Archives of biochemistry and biophysics.

[14]  H. Yamazaki,et al.  Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. , 1994, The Journal of pharmacology and experimental therapeutics.

[15]  J. Cannon,et al.  Beta-turn formation in the processing region is important for efficient maturation of Escherichia coli maltose-binding protein by signal peptidase I in vivo. , 1994, The Journal of biological chemistry.

[16]  G. F. Weber,et al.  Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. , 1993, Cancer research.

[17]  M. Waterman,et al.  Expression and purification of functional human 17 alpha-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17 alpha-hydroxylase/17,20-lyase deficiency. , 1993, The Journal of biological chemistry.

[18]  F. Guengerich,et al.  Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. , 1993, Archives of biochemistry and biophysics.

[19]  L. Aggerbeck,et al.  Cytoplasmic and periplasmic production of human apolipoprotein E in Escherichia coli using natural and bacterial signal peptides. , 1993, Gene.

[20]  A. Cederbaum,et al.  Expression of a catalytically active human cytochrome P-4502E1 in Escherichia coli. , 1992, Biochimica et biophysica acta.

[21]  G. von Heijne,et al.  A signal peptide with a proline next to the cleavage site inhibits leader peptidase when present in a sec‐independent protein , 1992, FEBS letters.

[22]  J. S. Miles,et al.  Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. , 1992, The Biochemical journal.

[23]  G. A. Barkocy-Gallagher,et al.  Synthesis of precursor maltose-binding protein with proline in the +1 position of the cleavage site interferes with the activity of Escherichia coli signal peptidase I in vivo. , 1992, The Journal of biological chemistry.

[24]  T. Shimada,et al.  Purification and characterization of human liver microsomal cytochrome P-450 2A6. , 1991, Molecular pharmacology.

[25]  M. J. Coon,et al.  Cytochrome P-450 : multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms , 1991 .

[26]  M. J. Coon,et al.  Alcohol-inducible cytochrome P-450IIE1 lacking the hydrophobic NH2-terminal segment retains catalytic activity and is membrane-bound when expressed in Escherichia coli. , 1991, The Journal of biological chemistry.

[27]  P. Beaune,et al.  Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1 , 1990 .

[28]  M. P. Arlotto,et al.  Human cytochrome P450IIA3: cDNA sequence role of the enzyme in the metabolic of promutagens comparison to nitrosamine activation by human cytochrome P450IIE1 , 1990 .

[29]  M. Inouye,et al.  Suppression of the negative effect of minor arginine codons on gene expression; preferential usage of minor codons within the first 25 codons of the Escherichia coli genes. , 1990, Nucleic acids research.

[30]  F. Gonzalez,et al.  The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. , 1990, Biochemistry.

[31]  J. Yon,et al.  Precise gene fusion by PCR. , 1989, Nucleic acids research.

[32]  T. E. Wilson,et al.  Structural analysis of the FMN binding domain of NADPH-cytochrome P-450 oxidoreductase by site-directed mutagenesis. , 1989, The Journal of biological chemistry.

[33]  J. S. Miles,et al.  Close linkage of the human cytochrome P450IIA and P450IIB gene subfamilies: implications for the assignment of substrate specificity. , 1989, Nucleic acids research.

[34]  P. Srivastava,et al.  Characterization of mRNA species related to human liver cytochrome P-450 nifedipine oxidase and the regulation of catalytic activity. , 1989, The Journal of biological chemistry.

[35]  M. Inouye,et al.  Signal peptidases recognize a structural feature at the cleavage site of secretory proteins. , 1988, The Journal of biological chemistry.

[36]  A. C. Looman,et al.  Influence of the codon following the AUG initiation codon on the expression of a modified lacZ gene in Escherichia coli. , 1987, The EMBO journal.

[37]  G. Heijne.  A new method for predicting signal sequence cleavage sites. , 1986 .

[38]  D. Waxman,et al.  Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. , 1986, The Journal of biological chemistry.

[39]  P. Novák,et al.  Localization and purification of two enzymes from Escherichia coli capable of hydrolyzing a signal peptide. , 1986, The Journal of biological chemistry.

[40]  W. Wickner,et al.  Leader peptidase catalyzes the release of exported proteins from the outer surface of the Escherichia coli plasma membrane. , 1985, The Journal of biological chemistry.

[41]  M. Inouye,et al.  Characterization of the lep operon of Escherichia coli. Identification of the promoter and the gene upstream of the signal peptidase I gene. , 1985, The Journal of biological chemistry.

[42]  P. Thomas,et al.  Regio- and stereoselective metabolism of two C19 steroids by five highly purified and reconstituted rat hepatic cytochrome P-450 isozymes. , 1983, The Journal of biological chemistry.

[43]  M. Macart,et al.  An improvement of the Coomassie Blue dye binding method allowing an equal sensitivity to various proteins: application to cerebrospinal fluid. , 1982, Clinica chimica acta; international journal of clinical chemistry.

[44]  M. Inouye,et al.  Gene structure of the OmpA protein, a major surface protein of Escherichia coli required for cell-cell interaction. , 1980, Journal of molecular biology.

[45]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[46]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[47]  K. Korzekwa,et al.  Cytochromes P450 Expression Systems , 1995 .

[48]  H. Nojima,et al.  High efficiency transformation of Escherichia coli with plasmids. , 1990, Gene.